Patents by Inventor Marie-Christophe Boissier

Marie-Christophe Boissier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic compounds comprising peptides of IL1?
    Patent number: 8632781
    Abstract: The present invention relates to peptides derived from the proinflammatory cytokines, interleukin-1? (IL1?) and tumor necrosis factor ? (TNF?), and their use in human or veterinary therapy, such as to generally treat diseases linked to the overproduction of IL1? or TNF? as well as acute or chronic inflammatory diseases, rheumatoid arthritis, septic shock, autoimmune diabetes, graft rejection in the host, etc.
    Type: Grant
    Filed: January 11, 2011
    Date of Patent: January 21, 2014
    Assignee: Vaxconsulting
    Inventors: Jean-Francois Zagury, Marie-Christophe Boissier, Natacha Bessis
  • Preparation Comprising Mycobacterium Bovis BCG Killed by Extended Freeze Drying (EFD) for Preventing or Treating Rheumatoid Arthritis
    Publication number: 20110033567
    Abstract: Preparation comprising Mycobacterium bovis BCG killed by Extended Freeze Drying (EFD) for preventing and/or treating rheumatoid arthritis.
    Type: Application
    Filed: February 6, 2009
    Publication date: February 10, 2011
    Inventors: Gilles Marchal, Micheline Lagranderie, Marie-Christophe Boissier, Natacha Bessis